Scaling up effective treatment of hypertension-A pathfinder for universal health coverage

被引:40
作者
Frieden, Thomas R. [1 ]
Varghese, Cherian V. [2 ]
Kishore, Sandeep P. [3 ,4 ]
Campbell, Norman R. C. [5 ]
Moran, Andrew E. [1 ,6 ]
Padwal, Raj [7 ]
Jaffe, Marc G. [1 ]
机构
[1] Resolve Save Lives, 100 Broadway,4th Floor, New York, NY 10005 USA
[2] WHO, Geneva, Switzerland
[3] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Univ Calgary, Calgary, AB, Canada
[6] Columbia Univ, New York, NY USA
[7] Univ Alberta, Edmonton, AB, Canada
关键词
clinical management of high blood pressure (HBP); combination therapy; general; hypertension; pharmacologic (drug) therapy; primary care issues; ANGIOTENSIN RECEPTOR BLOCKERS; CONVERTING ENZYME-INHIBITORS; HIGH BLOOD-PRESSURE; COMBINATION THERAPY; METAANALYSIS; MANAGEMENT; TELMISARTAN; MORTALITY; COUNTRIES; EFFICACY;
D O I
10.1111/jch.13655
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
High blood pressure is the world's leading cause of death, but despite treatment for hypertension being safe, effective, and low cost, most people with hypertension worldwide do not have it controlled. This article summarizes lessons learned in the first 2 years of the Resolve to Save Lives (RTSL) hypertension management program, operated in coordination with the World Health Organization (WHO) and other partners. Better diagnosis, treatment, and continuity of care are all needed to improve control rates, and five necessary components have been recommended by RTSL, WHO and other partners as being essential for a successful hypertension control program. Several hurdles to hypertension control have been identified, with most related to limitations in the health care system rather than to patient behavior. Treatment according to standardized protocols should be started as soon as hypertension is diagnosed, and medical practices and health systems must closely monitor patient progress and system performance. Improvement in hypertension management and control, along with elimination of artificial trans fat and reduction of dietary sodium consumption, will improve many aspects of primary care, contribute to goals for universal health coverage, and could save 100 million lives worldwide over the next 30 years.
引用
收藏
页码:1442 / 1449
页数:8
相关论文
共 38 条
[1]   The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases [J].
Abraham, Hazel Mae A. ;
White, C. Michael ;
White, William B. .
DRUG SAFETY, 2015, 38 (01) :33-54
[2]  
[Anonymous], 1979, JAMA-J AM MED ASSOC, V242, P2562
[3]   Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data [J].
Attaei, Marjan W. ;
Khatib, Rasha ;
McKee, Martin ;
Lear, Scott ;
Dagenais, Gilles ;
Igumbor, Ehimario U. ;
AlHabib, Khalid F. ;
Kaur, Manmeet ;
Kruger, Lanthe ;
Teo, Koon ;
Lanas, Fernando ;
Yusoff, Khalid ;
Oguz, Aytekin ;
Gupta, Rajeev ;
Yusufali, Afzalhussein M. ;
Bahonar, Ahmad ;
Kutty, Raman ;
Rosengren, Annika ;
Mohan, Viswanathan ;
Avezum, Alvaro ;
Yusuf, Rita ;
Szuba, Andrzej ;
Rangarajan, Sumathy ;
Chow, Clara ;
Yusuf, Salim .
LANCET PUBLIC HEALTH, 2017, 2 (09) :E411-E419
[4]   The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies? [J].
Campbell, Norm R. C. ;
Sheldon, Tobe .
CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) :366-372
[5]   Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension.: ETECUM-HTA study [J].
Contreras, EM ;
García, OV ;
Claros, NM ;
Guillén, VG ;
Von Wichmann, MD ;
Martínez, JJC ;
Fernández, R .
BLOOD PRESSURE, 2005, 14 (03) :151-158
[6]   The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? [J].
Dezsi, Csaba Andras .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (04) :255-266
[7]   Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications [J].
DiPette, Donald J. ;
Skeete, Jamario ;
Ridley, Emily ;
Campbell, Norm R. C. ;
Lopez-Jaramillo, Patricio ;
Kishore, Sandeep P. ;
Jaffe, Marc G. ;
Coca, Antonio ;
Townsend, Raymond R. ;
Ordunez, Pedro .
JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (01) :4-15
[8]   Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide A Retrospective Cohort Analysis [J].
Dorsch, Michael P. ;
Gillespie, Brenda W. ;
Erickson, Steven R. ;
Bleske, Barry E. ;
Weder, Alan B. .
HYPERTENSION, 2011, 57 (04) :689-+
[9]   Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol: Results at 6 and 12 Months [J].
Egan, Brent M. ;
Sutherland, Susan E. ;
Rakotz, Michael ;
Yang, Jianing ;
Hanlin, R. Bruce ;
Davis, Robert A. ;
Wozniak, Gregory .
HYPERTENSION, 2018, 72 (06) :1320-1327
[10]   Deaths Preventable in the US by Improvements in Use of Clinical Preventive Services [J].
Farley, Thomas A. ;
Dalal, Mehul A. ;
Mostashari, Farzad ;
Frieden, Thomas R. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 38 (06) :600-609